Summit X, LLC Palatin Technologies Inc Transaction History

Summit X, LLC

  • $383 Million
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 05, 2022
SELL
$0.37 - $0.54 $12,950 - $18,900
-35,000 Closed
0 $0
Q1 2020

May 13, 2020
BUY
$0.36 - $0.79 $900 - $1,975
2,500 Added 7.69%
35,000 $15,000
Q4 2019

Jan 23, 2020
BUY
$0.75 - $0.89 $1,875 - $2,225
2,500 Added 8.33%
32,500 $25,000
Q3 2019

Oct 15, 2019
BUY
$0.78 - $1.09 $11,700 - $16,350
15,000 Added 100.0%
30,000 $27,000
Q2 2019

Aug 13, 2019
BUY
$0.98 - $1.64 $14,700 - $24,600
15,000 New
15,000 $23,000

Others Institutions Holding PTN

# of Institutions
2
Shares Held
3.02K
Call Options Held
0
Put Options Held
0
View Full List

About PALATIN TECHNOLOGIES INC

PTN Quotes by TradingView
  • Ticker PTN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,290,480
  • Market Cap $16.7M
  • Description
  • Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...
More about PTN
Track This Portfolio

Track Summit X, LLC Portfolio

Follow Summit X, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit X, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email